{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:54:57Z","timestamp":1774407297715,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Health and Medical Care Executive Board of the V\u00e4stra G\u00f6taland"},{"name":"Rune and Ulla Aml\u00f6vs foundation for Rheumatology Research"},{"DOI":"10.13039\/501100008106","name":"G\u00f6teborg\u2019s Association Against Rheumatism","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008106","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Swedish Association Against Rheumatism"},{"name":"the Medical Society of G\u00f6teborg and the Region V\u00e4stra G\u00f6taland"},{"name":"COMBINE, the Margareta Rheuma research foundation"},{"name":"the Swedish Society of Medicine"},{"name":"Ulla Aml\u00f6vs foundation for Rheumatology Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00198-018-4721-4","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T07:28:48Z","timestamp":1539156528000},"page":"441-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis"],"prefix":"10.1007","volume":"30","author":[{"given":"L.","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-6413","authenticated-orcid":false,"given":"E.","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nurkkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Carlsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Forsblad-d\u2019Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"4721_CR1","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980\u2013984","journal-title":"J Rheumatol"},{"key":"4721_CR2","first-page":"82","volume":"3","author":"I Petrini","year":"2015","unstructured":"Petrini I (2015) Biology of MET: a double life between normal tissue repair and tumor progression. Ann Transl Med 3:82","journal-title":"Ann Transl Med"},{"key":"4721_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2183\/pjab.86.588","volume":"86","author":"T Nakamura","year":"2010","unstructured":"Nakamura T, Mizuno S (2010) The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 86:588\u2013610","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"4721_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-8981(02)00302-9","volume":"327","author":"H Funakoshi","year":"2003","unstructured":"Funakoshi H, Nakamura T (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327:1\u201323","journal-title":"Clin Chim Acta"},{"key":"4721_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","volume":"14","author":"N Molnarfi","year":"2015","unstructured":"Molnarfi N, Benkhoucha M, Funakoshi H, Nakamura T, Lalive PH (2015) Hepatocyte growth factor: a regulator of inflammation and autoimmunity. Autoimmun Rev 14:293\u2013303","journal-title":"Autoimmun Rev"},{"key":"4721_CR6","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1073\/pnas.93.15.7644","volume":"93","author":"M Grano","year":"1996","unstructured":"Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, Zallone AZ, Comoglio PM (1996) Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci U S A 93:7644\u20137648","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4721_CR7","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491\u201321494","journal-title":"J Biol Chem"},{"key":"4721_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/ard.59.6.455","volume":"59","author":"Y Yoshihara","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455\u2013461","journal-title":"Ann Rheum Dis"},{"key":"4721_CR9","doi-asserted-by":"publisher","first-page":"17068","DOI":"10.4238\/2015.December.16.7","volume":"14","author":"JW Gao","year":"2015","unstructured":"Gao JW, Zhang KF, Lu JS, Su T (2015) Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis. Genet Mol Res 14:17068\u201317078","journal-title":"Genet Mol Res"},{"key":"4721_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","volume":"41","author":"AE Koch","year":"1998","unstructured":"Koch AE (1998) Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41:951\u2013962","journal-title":"Arthritis Rheum"},{"key":"4721_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/ard.48.2.92","volume":"48","author":"BL Kidd","year":"1989","unstructured":"Kidd BL, Moore K, Walters MT, Smith JL, Cawley MI (1989) Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis. Ann Rheum Dis 48:92\u201398","journal-title":"Ann Rheum Dis"},{"key":"4721_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/ard.41.6.579","volume":"41","author":"PA Revell","year":"1982","unstructured":"Revell PA, Mayston V (1982) Histopathology of the synovial membrane of peripheral joints in ankylosing spondylitis. Ann Rheum Dis 41:579\u2013586","journal-title":"Ann Rheum Dis"},{"key":"4721_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2249.2003.02101.x","volume":"132","author":"M Drouart","year":"2003","unstructured":"Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, Toussirot E (2003) High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 132:158\u2013162","journal-title":"Clin Exp Immunol"},{"key":"4721_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1046\/j.1563-258X.2002.01118.x","volume":"152","author":"C Goldberger","year":"2002","unstructured":"Goldberger C, Dulak J, Duftner C, Weidinger F, Falkenbach A, Schirmer M (2002) Vascular endothelial growth factor (VEGF) in ankylosing spondylitis--a pilot study. Wien Med Wochenschr 152:223\u2013225","journal-title":"Wien Med Wochenschr"},{"key":"4721_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"4721_CR16","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013i44","journal-title":"Ann Rheum Dis"},{"key":"4721_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13075-017-1480-0","volume":"19","author":"A Deminger","year":"2017","unstructured":"Deminger A, Klingberg E, Lorentzon M, Geijer M, Gothlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d\u2019Elia H (2017) Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study. Arthritis Res Ther 19:273","journal-title":"Arthritis Res Ther"},{"key":"4721_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers MC, Franssen MJ, van\u2019t Hof MA, Gribnau FW, van de Putte LB, van Riel PL (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64:127\u2013129","journal-title":"Ann Rheum Dis"},{"key":"4721_CR19","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1517\/14728222.2016.1162293","volume":"20","author":"RN Frisch","year":"2016","unstructured":"Frisch RN, Curtis KM, Aenlle KK, Howard GA (2016) Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair. Expert Opin Ther Targets 20:1087\u20131098","journal-title":"Expert Opin Ther Targets"},{"key":"4721_CR20","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1007\/s11999-008-0493-z","volume":"466","author":"H Matsubara","year":"2008","unstructured":"Matsubara H, Tsuchiya H, Watanabe K, Takeuchi A, Tomita K (2008) Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study. Clin Orthop Relat Res 466:2962\u20132972","journal-title":"Clin Orthop Relat Res"},{"key":"4721_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1210\/endo.140.3.6553","volume":"140","author":"F Blanquaert","year":"1999","unstructured":"Blanquaert F, Delany AM, Canalis E (1999) Fibroblast growth factor-2 induces hepatocyte growth factor\/scatter factor expression in osteoblasts. Endocrinology 140:1069\u20131074","journal-title":"Endocrinology"},{"key":"4721_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-018-1665-1","volume":"20","author":"A Deminger","year":"2018","unstructured":"Deminger A, Klingberg E, Geijer M, Gothlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d\u2019Elia H (2018) A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis. Arthritis Res Ther 20:162","journal-title":"Arthritis Res Ther"},{"key":"4721_CR23","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1073\/pnas.0912437107","volume":"107","author":"M Benkhoucha","year":"2010","unstructured":"Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH (2010) Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 107:6424\u20136429","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4721_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1124\/jpet.103.054106","volume":"307","author":"Y Tahara","year":"2003","unstructured":"Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K, Tsubouchi H (2003) Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 307:146\u2013151","journal-title":"J Pharmacol Exp Ther"},{"key":"4721_CR25","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.4049\/jimmunol.179.8.5504","volume":"179","author":"K Okunishi","year":"2007","unstructured":"Okunishi K, Dohi M, Fujio K, Nakagome K, Tabata Y, Okasora T, Seki M, Shibuya M, Imamura M, Harada H, Tanaka R, Yamamoto K (2007) Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol 179:5504\u20135513","journal-title":"J Immunol"},{"key":"4721_CR26","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1186\/ar2012","volume":"8","author":"T Kuroiwa","year":"2006","unstructured":"Kuroiwa T, Iwasaki T, Imado T, Sekiguchi M, Fujimoto J, Sano H (2006) Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther 8:R123","journal-title":"Arthritis Res Ther"},{"key":"4721_CR27","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/ar3857","volume":"14","author":"DL Mattey","year":"2012","unstructured":"Mattey DL, Packham JC, Nixon NB, Coates L, Creamer P, Hailwood S, Taylor GJ, Bhalla AK (2012) Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. Arthritis Res Ther 14:R127","journal-title":"Arthritis Res Ther"},{"key":"4721_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/art.30163","volume":"63","author":"B Grandaunet","year":"2011","unstructured":"Grandaunet B, Syversen SW, Hoff M, Sundan A, Haugeberg G, van Der Heijde D, Kvien TK, Standal T (2011) Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis. Arthritis Rheum 63:662\u2013669","journal-title":"Arthritis Rheum"},{"key":"4721_CR29","first-page":"2184","volume":"21","author":"K Yukioka","year":"1994","unstructured":"Yukioka K, Inaba M, Furumitsu Y, Yukioka M, Nishino T, Goto H, Nishizawa Y, Morii H (1994) Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells. J Rheumatol 21:2184\u20132189","journal-title":"J Rheumatol"},{"key":"4721_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/030097401316909585","volume":"30","author":"AJ Feuerherm","year":"2001","unstructured":"Feuerherm AJ, Borset M, Seidel C, Sundan A, Leistad L, Ostensen M, Faxvaag A (2001) Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scand J Rheumatol 30:229\u2013234","journal-title":"Scand J Rheumatol"},{"key":"4721_CR31","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.22192","volume":"54","author":"A Capuano","year":"2006","unstructured":"Capuano A, Costanzi S, Peluso G, Zannoni G, Vellone VG, Gremese E, Zoli A, Scott C, Beltrami CA, Romano G, Ferraccioli G (2006) Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis. Arthritis Rheum 54:3633\u20133639","journal-title":"Arthritis Rheum"},{"key":"4721_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00005176-200111000-00007","volume":"33","author":"M Srivastava","year":"2001","unstructured":"Srivastava M, Zurakowski D, Cheifetz P, Leichtner A, Bousvaros A (2001) Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 33:548\u2013553","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4721_CR33","doi-asserted-by":"crossref","unstructured":"Owusu BY, Galemmo R, Janetka J, Klampfer L (2017) Hepatocyte growth factor, a key tumor-promoting factor in the tumor microenvironment. Cancers (Basel) 9","DOI":"10.3390\/cancers9040035"},{"key":"4721_CR34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V91.3.806","volume":"91","author":"C Seidel","year":"1998","unstructured":"Seidel C, Borset M, Turesson I, Abildgaard N, Sundan A, Waage A (1998) Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood 91:806\u2013812","journal-title":"Blood"},{"key":"4721_CR35","doi-asserted-by":"crossref","unstructured":"Bradley CA, Salto-Tellez M, Laurent-Puig P, et al (2017) Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges. Nat Rev Clin Oncol","DOI":"10.1038\/nrclinonc.2017.40"},{"key":"4721_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cas.13156","volume":"108","author":"K Matsumoto","year":"2017","unstructured":"Matsumoto K, Umitsu M, De Silva DM, Roy A, Bottaro DP (2017) Hepatocyte growth factor\/MET in cancer progression and biomarker discovery. Cancer Sci 108:296\u2013307","journal-title":"Cancer Sci"},{"key":"4721_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.20696","volume":"51","author":"C Yang","year":"2004","unstructured":"Yang C, Gu J, Rihl M, Baeten D, Huang F, Zhao M, Zhang H, Maksymowych WP, de Keyser F, Veys EM, Yu DTY (2004) Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum 51:691\u2013699","journal-title":"Arthritis Rheum"},{"key":"4721_CR38","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1002\/art.20477","volume":"50","author":"B Vandooren","year":"2004","unstructured":"Vandooren B, Kruithof E, Yu DT, Rihl M, Gu J, De Rycke L, Van Den Bosch F, Veys EM, De Keyser F, Baeten D (2004) Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. Arthritis Rheum 50:2942\u20132953","journal-title":"Arthritis Rheum"},{"key":"4721_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"CH Chen","year":"2006","unstructured":"Chen CH, Lin KC, Yu DT et al (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 45:414\u2013420","journal-title":"Rheumatology"},{"key":"4721_CR40","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landewe R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D (2007) Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 56:1846\u20131853","journal-title":"Arthritis Rheum"},{"key":"4721_CR41","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10067-010-1528-x","volume":"29","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, Hetland ML, Sorensen IJ, Ostergaard M, Nielsen HJ, Johansen JS (2010) Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFalpha inhibitors. Clin Rheumatol 29:1301\u20131309","journal-title":"Clin Rheumatol"},{"key":"4721_CR42","first-page":"2030","volume":"35","author":"WP Maksymowych","year":"2008","unstructured":"Maksymowych WP, Rahman P, Shojania K, Olszynski WP, Thomson GT, Ballal S, Wong RL, Inman RD, Group MS (2008) Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. J Rheumatol 35:2030\u20132037","journal-title":"J Rheumatol"},{"key":"4721_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14712\/18059694.2014.40","volume":"57","author":"M Tosovsky","year":"2014","unstructured":"Tosovsky M, Bradna P, Andrys C, Andrysova K, Cermakova E, Soukup T (2014) The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors. Acta Med (Hradec Kralove) 57:56\u201361","journal-title":"Acta Med (Hradec Kralove)"},{"key":"4721_CR44","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/ard.2010.138883","volume":"70","author":"SJ Pedersen","year":"2011","unstructured":"Pedersen SJ, Sorensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Moller J, Hasselquist M, Mikkelsen D, Skjodt T, Lambert R, Hansen A, Ostergaard M (2011) ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFalpha inhibitors. Ann Rheum Dis 70:1375\u20131381","journal-title":"Ann Rheum Dis"},{"key":"4721_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3899\/jrheum.150897","volume":"43","author":"J Braun","year":"2016","unstructured":"Braun J, Baraliakos X, Hermann KG, Xu S, Hsu B (2016) Serum vascular endothelial growth factor levels lack predictive value in patients with active ankylosing spondylitis treated with golimumab. J Rheumatol 43:901\u2013906","journal-title":"J Rheumatol"},{"key":"4721_CR46","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1136\/annrheumdis-2013-203824","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy D, Conrad K, Haibel H, Syrbe U, Appel H, Braun J, Rudwaleit M, Sieper J (2014) Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis. Ann Rheum Dis 73:2137\u20132143","journal-title":"Ann Rheum Dis"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4721-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T01:40:29Z","timestamp":1572054029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4721-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4721"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4721-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"assertion":[{"value":"5 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}